BOSTON SCIENTIFIC CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.17 USD | -0.61% |
|
-0.66% | +30.03% |
| May. 28 | Argus Adjusts Price Target on Boston Scientific to $95 From $80 | MT |
| May. 23 | Boston Scientific Insider Sold Shares Worth $2,504,239, According to a Recent SEC Filing | MT |
Presenter SpeechTravis Steed (Analysts)[Audio Gap] Daniel Brennan, Chief Financial Officer; Dr...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
75.17
USD
Average target price
81.53
USD
Spread / Average Target
+8.46%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +30.03% | 111B | |
| +7.87% | 219B | |
| +11.83% | 192B | |
| +18.87% | 142B | |
| +2.32% | 65.32B | |
| +14.15% | 52.45B | |
| +2.68% | 49.8B | |
| +6.60% | 43.43B | |
| +1.85% | 35.95B | |
| +20.43% | 30.43B |
- Stock Market
- Equities
- BSX Stock
- News Boston Scientific Corporation
- Transcript : Boston Scientific Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 08
